Back
Range Cancer Therapeutics ETF Stock Price Chart
Invest. Do Good. Get Rewarded. Just $0.26/Share!
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
47
CNCR
Range Cancer Therapeutics ETF
Last Price:
13.62
Seasonality Move:
2.55%
7 Day Trial
ALL ACCESS PASS
$
7
Trade on Tuesday. Profit on Friday. Rinse & Repeat
Get the full details now.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CNCR is experiencing slight buying pressure.
Range Cancer Therapeutics ETF Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.68 | Sell |
| 20-day SMA: | 14.6 | Sell |
| 50-day SMA: | 14.86 | Sell |
| 200-day SMA: | 15.05 | Sell |
| 8-day EMA: | 13.76 | Sell |
| 20-day EMA: | 14.32 | Sell |
| 50-day EMA: | 14.66 | Sell |
| 200-day EMA: | 14.55 | Sell |
Range Cancer Therapeutics ETF Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.43 | Sell |
| Relative Strength Index (14 RSI): | 36.72 | Sell |
| Chaikin Money Flow: | 1180 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (13.87 - 15.47) | Sell |
| Bollinger Bands (100): | (14.08 - 15.46) | Sell |
Range Cancer Therapeutics ETF Technical Analysis
| Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | Nov 21 | Nov 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Range Cancer Therapeutics ETF Stock
Is Range Cancer Therapeutics ETF Stock a Buy?
- Range Cancer Therapeutics ETF share price is 13.56 while CNCR 8-day simple moving average is 13.68, which is a Sell signal.
- The stock price of CNCR is 13.56 while Range Cancer Therapeutics ETF 20-day SMA is 14.60, which makes it a Sell.
- Range Cancer Therapeutics ETF 50-day simple moving average is 14.86 while CNCR share price is 13.56, making it a Sell technically.
- CNCR stock price is 13.56 and Range Cancer Therapeutics ETF 200-day simple moving average is 15.05, creating a Sell signal.
CNCR Technical Analysis vs Fundamental Analysis
Sell
47
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Is Range Cancer Therapeutics ETF a Buy or a Sell?
-
Range Cancer Therapeutics ETF stock is rated a Sell
The current Range Cancer Therapeutics ETF [CNCR] share price is $13.56. The Score for CNCR is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
Range Cancer Therapeutics ETF Stock Info
Market Cap:
0
Price in USD:
13.56
Share Volume:
3.56K
Range Cancer Therapeutics ETF 52-Week Range
52-Week High:
17.96
52-Week Low:
10.49
Sell
47
Range Cancer Therapeutics ETF (CNCR)
is a Sell
Range Cancer Therapeutics ETF Share Price Forecast
-
What is the Range Cancer Therapeutics ETF stock price today?
The Range Cancer Therapeutics ETF stock price is 13.56 USD today. -
Will CNCR stock go up or go down?
Range Cancer Therapeutics ETF> share price is forecast to RISE/FALL based on technical indicators -
Is Range Cancer Therapeutics ETF overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Range Cancer Therapeutics ETF is overvalued.
Is Range Cancer Therapeutics ETF Stock a Buy?
- Range Cancer Therapeutics ETF share price is 13.56 while CNCR 8-day exponential moving average is 13.76, which is a Sell signal.
- The stock price of CNCR is 13.56 while Range Cancer Therapeutics ETF 20-day EMA is 14.32, which makes it a Sell.
- Range Cancer Therapeutics ETF 50-day exponential moving average is 14.66 while CNCR share price is 13.56, making it a Sell technically.
- CNCR stock price is 13.56 and Range Cancer Therapeutics ETF 200-day simple moving average is 14.55, creating a Sell signal.
Technical Analysis of Range Cancer Therapeutics ETF
Should I short Range Cancer Therapeutics ETF stock?
- CNCR Moving Average Covergence Divergence (MACD) indicator is -0.43, suggesting Range Cancer Therapeutics ETF is a Sell
- Range Cancer Therapeutics ETF Relative Strength Index (RSI) is 36.72, which suggest Range Cancer Therapeutics ETF is oversold
- The Bollinger Bands (25) for Range Cancer Therapeutics ETF is (13.87 - 15.47), which suggest Range Cancer Therapeutics ETF is a Sell
- The Bollinger Bands (100) for Range Cancer Therapeutics ETF is (14.08 - 15.46), which suggest Range Cancer Therapeutics ETF is a Sell
* Range Cancer Therapeutics ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.